Delivery Order SPE2DB22D1106-SPE2DB24FFEU1

Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of albuterol HFA 90 mcg inhalers. The contract is a firm fixed-price Delivery Order with a ceiling value of $2,590.75 and an ultimate completion date of September 19, 2024. The contract has no set-aside designation. As a significant federal contractor, Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Albuterol HFA 90 mcg inhalers. The contract has a ceiling value of $1,090.59 and a completion date of August 5, 2024. It is a Firm Fixed Price contract, with no set-aside designation. Amerisourcebergen has been awarded numerous federal contracts by various agencies, including a $7,570,000 definitive contract with the Office of the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Albuterol HFA 90 MCG inhalers. The contract has a firm-fixed-price of $1,997.88 and a period of performance through November 16, 2023. The award is not designated under any set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Albuterol HFA 90 MCG inhalers. The contract has a ceiling value of $1,980.76 and a period of performance through March 12, 2025. It is a firm-fixed price contract without any set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of albuterol HFA 90 mcg inhalers. The contract has a ceiling value of $1,739.61 and a period of performance through November 14, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract was not set aside for any specific business category. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of Albuterol HFA 90 MCG Inhalers. The total ceiling value of the contract is $1,346.34, and it has an ultimate completion date of September 10, 2024. This is a delivery order contract with a firm fixed-price pricing type. The contract is not set aside for any specific business category. AmerisourceBergen, a major pharmaceutical distributor, has been...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Albuterol HFA 90mcg inhalers, which are likely medical products used to treat respiratory conditions. The contract has a ceiling value of $2,753.74 and a completion date of June 3, 2025. It is a Firm Fixed Price contract, indicating a pre-determined price for the goods....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of Albuterol HFA 90 mcg inhalers, with a ceiling value of $2,783.41 and a completion date of September 26, 2024. The contract is a Firm Fixed Price type. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical commodities to various government agencies, including the military. The company holds several...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Albuterol HFA 90 MCG Inhalers with a ceiling value of $1,923.84. The contract is a Firm Fixed Price arrangement and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Albuterol HFA 90 MCG Inhaler 8.5GM, a critical medical commodity used in healthcare. The contract has a ceiling value of $4,783.72 and runs through March 17, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen holds a significant...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFEU1
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Albuterol HFA 90 MCG inhalers. The contract has a ceiling value of $2,072.37 and a period of performance through July 31, 2024. It is a firm fixed-price contract without a set-aside designation.

AmerisourceBergen, a major pharmaceutical distributor, has been awarded various federal contracts and indefinite delivery contracts (IDCs) to provide a wide range of pharmaceutical and medical products to support military treatment facilities, veterans' hospitals, and other government healthcare programs. Their current IDCs with the DLA and Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, serve as primary vehicles for delivering these essential medical commodities to federal agencies.

Generated 10/29/24, 9:21 AM